
GNS DEADLINE: ROSEN, A LONGSTANDING FIRM, Encourages Genius Group Limited Investors to Secure Counsel Before Important August 28 Deadline in Securities Class Action Against Citadel Securities LLC and Virtu Americas LLC - GNS
Newsfile Corp
Published: Aug 20, 2026, 02:12 AM
Sentiment Analysis
Rosen Law Firm, a global investor rights law firm, reminds purchasers or sellers of securities of Genius Group Limited (NYSE American: GNS) between April 12, 2022 and May 30, 2025, inclusive (the "Class Period"), of the important August 28, 2026 lead plaintiff deadline.
If you purchased or sold Genius securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than August 28, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
According to the lawsuit, throughout the Class Period, defendants engaged in a manipulative and illegal trading practice known as "spoofing," which involves submitting and then cancelling buy or sell orders without any genuine intent to execute them. The purpose of these "baiting orders" was to mislead other market participants about the true level of supply and demand for Genius securities, or about the stock's price volatility, thereby influencing the market price of Genius to benefit defendants' own trading positions.
The alleged manipulation also increased investors' transaction costs by inflating the bid-ask spread for Genius stock. Defendants entered thousands of these baiting orders on U.S. stock exchanges to create the false impression that Genius' stock price reflected genuine supply-and-demand and volatility dynamics, while simultaneously profiting by absorbing and reselling their customers' order flow at prices favorable to defendants.
Source: Newsfile Corp
This content is not intended as investment advice or a recommendation. Any opinions expressed are solely the personal views of each article.